The Cooper Companies, Inc. (COO)
NASDAQ: COO · Real-Time Price · USD
71.14
+1.45 (2.08%)
At close: Jun 27, 2025, 4:00 PM
71.28
+0.14 (0.20%)
After-hours: Jun 27, 2025, 7:03 PM EDT
The Cooper Companies Market Cap
The Cooper Companies has a market cap or net worth of $14.19 billion as of June 27, 2025. Its market cap has decreased by -25.03% in one year.
Market Cap
14.19B
Enterprise Value
16.94B
1-Year Change
-25.03%
Ranking
Category
Stock Price
$71.14
Market Cap Chart
Since December 1, 1998, The Cooper Companies's market cap has increased from $343.00M to $14.19B, an increase of 4,037.99%. That is a compound annual growth rate of 15.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2025 | 13.90B | -24.22% |
| Dec 31, 2024 | 18.35B | -2.11% |
| Dec 29, 2023 | 18.74B | 14.84% |
| Dec 30, 2022 | 16.32B | -21.16% |
| Dec 31, 2021 | 20.70B | 15.98% |
| Dec 31, 2020 | 17.85B | 13.22% |
| Dec 31, 2019 | 15.76B | 25.81% |
| Dec 31, 2018 | 12.53B | 17.70% |
| Dec 29, 2017 | 10.65B | 24.74% |
| Dec 30, 2016 | 8.53B | 31.73% |
| Dec 31, 2015 | 6.48B | -17.01% |
| Dec 31, 2014 | 7.81B | 31.32% |
| Dec 31, 2013 | 5.94B | 32.57% |
| Dec 31, 2012 | 4.48B | 32.89% |
| Dec 30, 2011 | 3.37B | 30.65% |
| Dec 31, 2010 | 2.58B | 49.73% |
| Dec 31, 2009 | 1.72B | 133.05% |
| Dec 31, 2008 | 740.10M | -56.66% |
| Dec 31, 2007 | 1.71B | -14.69% |
| Dec 29, 2006 | 2.00B | -11.68% |
| Dec 30, 2005 | 2.27B | -1.89% |
| Dec 31, 2004 | 2.31B | 55.88% |
| Dec 31, 2003 | 1.48B | 93.25% |
| Dec 31, 2002 | 766.90M | 1.37% |
| Dec 31, 2001 | 756.50M | 32.67% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 714.60B |
| Johnson & Johnson | 366.42B |
| AbbVie | 330.41B |
| Novo Nordisk | 301.06B |
| UnitedHealth Group | 275.46B |
| Abbott Laboratories | 234.83B |
| Novartis AG | 231.01B |
| AstraZeneca | 216.45B |